Bio Forge Pro Max – The Ultimate Bodybuilding Dietary Supplement

Print  | 

The latest supplement in the Bio Forge Bodybuilding range

New York City, N.Y, June 1, 2010 — Biotivia Bioceuticals, a leading manufacturer and distributor of Resveratrol based supplements, has formulated an all-natural muscle building product called Bio Forge Pro Max that compliments their already best selling Bio Forge lean mass building supplement range.

For 24 months, the scientists at Biotivia have been working in conjunction with some of the worlds best athletes and pharmacologists to create a new generation, safe, bodybuilding dietary supplement that increases muscle definition, reduces fat density and improves recovery times … all this without the normal side-effects attributed to other bodybuilding products.

James Betz, CEO and founder of Biotivia said: “Bio Forge Pro Max is the ultimate answer to every bodybuilder’s and extreme athelete’s demand. Our results have shown a huge improvement in overall strength, muscle mass and recovery time after training.”

Biotivia has combined an all-natural mix of Forskolin, Fadogia Agrestis, Cholecalciferol and 7-methoxyflavone in a supplement that increases anabolic and thermogenic conditioning, boosts lipolysis and contains aromatase inhibitors, which help to lower estrogen levels whilst causing an increase in testosterone levels.

Betz goes on to say: “Bio Forge Pro Max is the most scientifically advanced and safest supplement currently available. It has been tested by real hard-core bodybuilders and athletes who have achieved documented results.” This addition to our fitness line is not meant to replace Bio Forge, the fastest growing new body building supplement in the US. The two lean mass builders work along separate biological pathways and are meant to compliment each other for optimum results.

Bio Forge Pro Max can be seen, along with Biotivia’s other Resveratrol supplement range at http://www.biotivia.com/bioforgepromax.html

If you want to be kept upto date on the latest research and development then click here to subscribe to the Biotivia newsletter.

About Biotivia Bioceuticals

Biotivia was established in 1992 in Vienna, Austria as a supplier of natural raw materials and botanicals to the supplement and functional food industries and to researchers and scientific institutions worldwide. The company evolved into one of the world’s leading developers and suppliers of potent vitamin supplements and skin care therapies, with most of their products centered around the use of concentrated Resveratrol, the wildly popular red wine extract attributed to longevity plus many other beneficial effects.

Biotivia presently has US offices in New York, Los Angeles, Kansas City and international offices in the UK, Spain, Austria, Denmark, Italy, Germany, Singapore, Xi’an, China and Mumbai, India.

Beyond its strong consumer base, the company currently supplies researchers, physicians and scientists at Harvard, Stanford, Yale, Georgetown, The Albert Einstein Medical Center, University of Texas, M.D. Anderson Cancer Center and the University of California.

Transmax and Bioforte in particular are being tested by several major universities as a possible treatment for a variety of conditions that seriously impair the health and well being of millions of people around the world.

Biotivia’s Resveratrol products, Transmax and Bioforte, have been independently assessed by Consumer Labs, the leading American quality watchdog, and were deemed both ‘most potent’ and ‘best value’ resveratrol supplements.

All of Biotivia’s supplements are also certified Vegan by the American Vegetarian Association.

Other press releases from Biotivia Bioceuticals LLC

• Anti-diabetic potential of resveratrol shown in study - September 2nd, 2011
• Biotivia Launch New Pterostilbene Supplement Called PteroActiv - August 23rd, 2011
• Resveratrol Could Benefit Type 2 Diabetics - August 23rd, 2011
• PteroActiv, the new pterostilbene supplement from Biotivia - August 16th, 2011
• Bowel Disorders Can Be Eased With Probiotic Supplements - August 16th, 2011